Page last updated: 2024-09-05

isospaglumic acid and azelastine

isospaglumic acid has been researched along with azelastine in 2 studies

Compound Research Comparison

Studies
(isospaglumic acid)
Trials
(isospaglumic acid)
Recent Studies (post-2010)
(isospaglumic acid)
Studies
(azelastine)
Trials
(azelastine)
Recent Studies (post-2010) (azelastine)
46931116564160112

Protein Interaction Comparison

ProteinTaxonomyisospaglumic acid (IC50)azelastine (IC50)
Cytochrome P450 2D6Homo sapiens (human)1
Muscarinic acetylcholine receptor M1Homo sapiens (human)6.3096
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.1

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blondin, C; Cholley, B; Goldschmidt, P; Haeffner-Cavaillon, N1
Montero, JA; Pastor, S; Rodriguez, AE; Ruiz-Moreno, JM; Sanchis-Merino, ME1

Other Studies

2 other study(ies) available for isospaglumic acid and azelastine

ArticleYear
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
    Journal francais d'ophtalmologie, 2003, Volume: 26, Issue:4

    Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; Conjunctivitis; Cosmetics; Dibenzoxepins; Dipeptides; Drug Evaluation; Dust; Humans; In Vitro Techniques; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Oxamic Acid; Phthalazines; Piperidines; Pollen; Silicon Dioxide; Zymosan

2003
Comparative efficacy of topical antihistamines in an animal model of early phase allergic conjunctivitis.
    Experimental eye research, 2008, Volume: 86, Issue:5

    Topics: Animals; Anti-Allergic Agents; Benzimidazoles; Coloring Agents; Conjunctivitis, Allergic; Dibenzoxepins; Dipeptides; Disease Models, Animal; Drug Evaluation, Preclinical; Evans Blue; Guinea Pigs; Histamine H1 Antagonists; Ketotifen; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Phthalazines; Severity of Illness Index; Treatment Outcome

2008